Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Leif Erik Sander"'
Autor:
Christoph Zeyen, Maria Kinberger, Helene Kriedemann, Frieder Pfäfflin, Pinkus Tober-Lau, Leu Huang, Victor Max Corman, Alexander Nast, Leif Erik Sander, Florian Kurth, Ricardo Niklas Werner
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Cases of mpox have been reported worldwide since May 2022. Limited knowledge exists regarding the long-term course of this disease. To assess sequelae in terms of scarring and quality of life (QoL) in mpox patients 4–6 months af
Externí odkaz:
https://doaj.org/article/941ff9764f864744adcb5eacab6dce94
Autor:
Mikhail Lebedin, Christoph Ratswohl, Amar Garg, Marta Schips, Clara Vázquez García, Lisa Spatt, Charlotte Thibeault, Benedikt Obermayer, January Weiner, 3rd, Ilais Moreno Velásquez, Cathrin Gerhard, Paula Stubbemann, Leif-Gunnar Hanitsch, Tobias Pischon, Martin Witzenrath, Leif Erik Sander, Florian Kurth, Michael Meyer-Hermann, Kathrin de la Rosa
Publikováno v:
iScience, Vol 27, Iss 3, Pp 109330- (2024)
Summary: Identifying immune modulators that impact neutralizing antibody responses against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is of great relevance. We postulated that high serum concentrations of soluble angiotensin-co
Externí odkaz:
https://doaj.org/article/7c9c5701df2748eb9bb1238451f24137
Autor:
Gregor Lichtner, Thomas Haese, Sally Brose, Larissa Röhrig, Liudmila Lysyakova, Stefanie Rudolph, Maria Uebe, Julian Sass, Alexander Bartschke, David Hillus, Florian Kurth, Leif Erik Sander, Falk Eckart, Nicole Toepfner, Reinhard Berner, Anna Frey, Marcus Dörr, Jörg Janne Vehreschild, Christof von Kalle, Sylvia Thun
Publikováno v:
JMIR Medical Informatics, Vol 11, p e45496 (2023)
BackgroundThe COVID-19 pandemic has spurred large-scale, interinstitutional research efforts. To enable these efforts, researchers must agree on data set definitions that not only cover all elements relevant to the respective medical specialty but al
Externí odkaz:
https://doaj.org/article/3b738d986e2844bebcde78d4345b7a13
Autor:
Carmen Scheibenbogen, Judith Theresia Bellmann-Strobl, Cornelia Heindrich, Kirsten Wittke, Elisa Stein, Christiana Franke, Harald Prüss, Hannah Preßler, Marie-Luise Machule, Heinrich Audebert, Carsten Finke, Hanna Gwendolyn Zimmermann, Birgit Sawitzki, Christian Meisel, Markus Toelle, Anne Krueger, Anna C. Aschenbrenner, Joachim L. Schultze, Marc D. Beyer, Markus Ralser, Michael Mülleder, Leif Erik Sander, Frank Konietschke, Friedemann Paul, Silvia Stojanov, Lisa Bruckert, Dennis M. Hedderich, Franziska Knolle, Gabriela Riemekasten, Maria J. G. T. Vehreschild, Oliver A. Cornely, Uta Behrends, Susen Burock
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
The sequela of COVID-19 include a broad spectrum of symptoms that fall under the umbrella term post-COVID-19 condition or syndrome (PCS). Immune dysregulation, autoimmunity, endothelial dysfunction, viral persistence, and viral reactivation have been
Externí odkaz:
https://doaj.org/article/0761eebcbe8f474bb52b7ac6562159d3
Autor:
Bowen Zhang, Zhenhua Zhang, Valerie A.C.M. Koeken, Saumya Kumar, Michelle Aillaud, Hsin-Chieh Tsay, Zhaoli Liu, Anke R.M. Kraft, Chai Fen Soon, Ivan Odak, Berislav Bošnjak, Anna Vlot, Morris A. Swertz, Uwe Ohler, Robert Geffers, Thomas Illig, Jochen Huehn, Antoine-Emmanuel Saliba, Leif Erik Sander, Reinhold Förster, Cheng-Jian Xu, Markus Cornberg, Leon N. Schulte, Yang Li
Publikováno v:
Cell Genomics, Vol 3, Iss 2, Pp 100232- (2023)
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes severe COVID-19 in some patients and mild COVID-19 in others. Dysfunctional innate immune responses have been identified to contribute to COVID-19 severity, but th
Externí odkaz:
https://doaj.org/article/1d8a821dff98448fb35c91743f5b812b
Autor:
Frédéric Muench, Martin Krusche, Leif Erik Sander, Thomas Rose, Gerd-Rüdiger Burmester, Udo Schneider
Publikováno v:
BMC Rheumatology, Vol 5, Iss 1, Pp 1-4 (2021)
Abstract Background Adult-onset Still’s disease (AOSD) is an autoinflammatory multi-systemic syndrome. Macrophage activation syndrome (MAS) is a potentially life-threatening complication of AOSD with a mortality rate of 10–20%. Especially viral i
Externí odkaz:
https://doaj.org/article/51e3b5f340c94f26a1f7a86ebbd5a111
Autor:
Tatjana Schwarz, Gerd-Rüdiger Burmester, Florian Kurth, Jan Zernicke, Jens Klotsche, Tanja Braun, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Veronika Scholz, Lara Maria Jeworowski, Victor Max Corman, Pinkus Tober-Lau, Leif Erik Sander
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective The development of sufficient COVID-19 vaccines has been a big breakthrough in fighting the global SARS-CoV-2 pandemic. However, vaccination effectiveness can be reduced in patients with autoimmune rheumatic diseases (AIRD). The aim of this
Externí odkaz:
https://doaj.org/article/d451d62071de47d792f57340df2d8499
Autor:
Ziyue Wang, Pinkus Tober‐Lau, Vadim Farztdinov, Oliver Lemke, Torsten Schwecke, Sarah Steinbrecher, Julia Muenzner, Helene Kriedemann, Leif Erik Sander, Johannes Hartl, Michael Mülleder, Markus Ralser, Florian Kurth
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 11, Pp n/a-n/a (2022)
Abstract The rapid rise of monkeypox (MPX) cases outside previously endemic areas prompts for a better understanding of the disease. We studied the plasma proteome of a group of MPX patients with a similar infection history and clinical manifestation
Externí odkaz:
https://doaj.org/article/c8124d021574465f89bd6a63f7db6a43
Autor:
Robert Biesen, Florian Kurth, Jan Zernicke, Florian Klein, Jens Klotsche, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Alexander ten Hagen, Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Fredrik Nils Albach, Elvin Ahmadov, Leif Erik Sander
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective The level of neutralising capacity against Omicron BA.1 and BA.2 after third COVID-19 vaccination in patients on paused or continuous methotrexate (MTX) therapy is unclear.Methods In this observational cohort study, neutralising serum activ
Externí odkaz:
https://doaj.org/article/84ca7dad6d3b427d82aed33a4720b1b0
Autor:
Pinkus Tober-Lau, Henning Gruell, Kanika Vanshylla, Willi M. Koch, David Hillus, Philipp Schommers, Isabelle Suárez, Norbert Suttorp, Leif Erik Sander, Florian Klein, Florian Kurth
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 5, Pp 1050-1052 (2022)
To determine neutralizing activity against the severe acute respiratory syndrome coronavirus 2 ancestral strain and 4 variants of concern, we tested serum from 30 persons with breakthrough infection after 2-dose vaccination. Cross-variant neutralizin
Externí odkaz:
https://doaj.org/article/4cc3d635c8a94f9985a3a25698bb2443